Moreover, clinical studies and cellular experiments have demonstrated that SRC-3 promotes numerous aspects of cancer—such as cancer initiation, progression, and chemoresistance—through the integration of nuclear hormone receptors (or other transcription factors) and multiple cancer-growth pathways18. Here, NR0B1 is linked to cancer.